Skip to main content

Table 1 Patient demographics

From: Proteasome subunit expression analysis and chemosensitivity in relapsed paediatric acute leukaemia patients receiving bortezomib-containing chemotherapy

 

ALL (n = 68)

AML (n = 16)

Age, years median (range)

9.9 (1.5–23.7)

9.6 (1.0–19.6)

Sex

 Female

22

9

 Male

46

7

Race

 Caucasian

47

10

 Black-American

9

1

 Asian/Indian

5

4

 Native American/Hawaiian

1

0

 Other/unknown

6

1

Ethnicity

 Hispanic

21

3

 Non-Hispanic

46

11

 Unknown

1

2

Performance score (ECOG)

 0

56

9

 1

9

7

 2

3

0

WBC median, 109/L (range)

12.8 (0.3–201.1)

11.6 (0.5–61.8)

ALL histologic subtype

 pre-B ALL

52

 

 T-ALL

16

 

AML type

 Relapsed

 

11

 Secondary

 

5

AML: prior BMT

 No

 

12

 Yes

 

4